DLA Piper Adds Merck SVP As New Life Sciences Sector Chair
By Christine DeRosa · March 5, 2024, 4:33 PM EST
An experienced in-house attorney with a longtime passion for life sciences and medicine has left her position as a C-suite executive at biopharmaceutical giant Merck to join DLA Piper as the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login